See All Slides - tctmd.com

Slides

Presentation TCT 2016

A Complex Transradial Peripheral Case

Presenter: Francesco Burzotta, Shigeru Saito, Zoltan Ruzsa

October 30, 2016

Presentation TCT 2016

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, C. Michael Gibson

October 30, 2016

Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Brian K. Whisenant

October 30, 2016

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for "Outside the Box" Conditions

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Adam Witkowski

October 30, 2016

Presentation TCT 2016

Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: Clinical Updates

Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Danny Dvir

October 30, 2016

Presentation TCT 2016

Prognosis and Treatment Options for DES Restenosis and Re-restenosis

Presenter: Fernando Alfonso, Stephan Windecker

October 30, 2016

Presentation TCT 2016

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others)

Presenter: Scott Berry, Stuart J. Pocock, Ajay J. Kirtane

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Corrado Tamburino

October 30, 2016

Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Left Main Stenting: Fascinating Cases and Lessons From the EXCEL Angiographic Core Lab

Presenter: David E. Kandzari, Jens Flensted Lassen, Philippe Généreux

October 30, 2016

Advertisement

Slides

A Complex Transradial Peripheral Case

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes!

Beyond Hypertension: Autonomic Modulation Therapies for "Outside the Box" Conditions

Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: Clinical Updates

Prognosis and Treatment Options for DES Restenosis and Re-restenosis

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others)

Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Left Main Stenting: Fascinating Cases and Lessons From the EXCEL Angiographic Core Lab

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content